Malignant Bile Duct Neoplasm — Trials

Malignant Bile Duct Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

883 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 223
Recruiting: 126
Ph III recruiting: 7
Growth YoY: +14.6%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (119)

clinicaltrialsPublishedShowing 151–168 of 168 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06298968	Combined Therapy Using Gemcitabine and Cisplatin Chemotherapy, Lenvatinib and Adebrelimab for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma	recruiting	Phase 2	38	Nanfang Hospital, Southern Medical UniversityOTHER	1	Jul 3, 2024	clinicaltrials
NCT04340986	Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma(CHC/CC)	recruiting	—	1,250	Assistance Publique - Hôpitaux de ParisOTHER